Jason Ezra Hawkes, M.D., M.S., F.A.A.D.

Philosophy of Care
My philosophy of care is to maximize treatment response and the prevention of dermatologic conditions in patients while simultaneously minimizing unnecessary treatments and their associated risks.

Clinical and Research Interest
Dr. Hawkes is a board-certified dermatologist and Associate Professor of Dermatology at the University of California Davis in Sacramento. He completed his medical degree and dermatology residency training at the University of Utah School of Medicine, where he was also enrolled in the Program’s 2+2 dermatology research track. In addition to his clinical training, Dr. Hawkes completed a research fellowship in translation immunology at the National Institutes of Health as part of the HHMI-NIH Research Scholars Program and received a master’s degree in Clinical Investigation from Rockefeller University in NYC.

Dr. Hawkes’ principal clinical and research interests are the treatment of complex inflammatory skin diseases, such as psoriasis, psoriatic arthritis, hidradenitis suppurativa, and eczema. He has a special interest in translational human research and the development of novel biologics and small molecules used for the treatment of inflammatory conditions.

Dr. Hawkes is currently serving on the Medical Board of the National Psoriasis Foundation and has served as the Principal Investigator and Co-Investigator of multiple pharmaceutical-sponsored and investigator-initiated clinical trial protocols. He is the recipient of multiple research grants and teaching awards and was recently named the 2021 Outstanding Educator in Psoriatic Disease by the National Psoriasis Foundation. He is the author of more than 50 peer-reviewed publications and 8 book chapters.

Undergraduate Education: Brigham Young University

Medical Education: University of Utah School of Medicine 2011

Internship: Boise VA Medical Center/University of Washington, Internal Medicine

Residency: University of Utah Medical Center, Dermatology 2015

Selected Recent Peer-reviewed Publications:

1. Bloomstein JD, Hawkes JE. Simultaneous treatment of Samter triad and prurigo nodularis with dupilumab. JAAD Case Rep. 2021 Oct 15;18:20-22. doi: 10.1016/j.jdcr.2021.10.005. PMID: 34778501; PMCID: PMC8577416.
2. Guttman-Yassky E, Renert-Yuval Y, Bares J, Margot C, Hawkes J, Gilleaudeau P, Sullivan-Whalen M, Singer GK, Garcet S, Pavel AB, Lebwohl MG, Krueger JG. Phase 2a Trial of Dupilumab (anti-IL-4Rα) for Alopecia Areata Patients. Allergy. 2021 Aug 30. Online ahead of print.
3. Hawkes JE, See K, Burge R, Strakbein S, McKean-Matthews M, Saure D, Gooderham M, Leonardi C. Dynamic Visual Representation of Clinical Efficacy of Ixekizumab in Psoriasis. Dermatologic Therapy. 2021 Aug 11; (4):1107-1118.
4. Frew JW, Hawkes JE, and Krueger JG. Topical, systemic and biologic therapies in hidradenitis suppurativa: pathogenic insights through examination of therapeutic mechanisms. Therapeutic Advances in Chronic Disease. 2019 Mar 1; 10:2040622319830646.
5. Hawkes JE, Yan BY, Chan TC, Krueger JG. Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis. Journal of Immunology. 2018 Sep 15; 201(6):1605-1613.
6. Hawkes JE, Adalsteinsson JA, Gudjonnson JE, Ward NL. Research Techniques Made Simple: Murine Models of Human Psoriasis. Journal of Investigative Dermatology. 2017 Dec; 138(1):e1-e8
7. Hawkes JE, Chan TC, Krueger JG. Psoriasis pathogenesis and the development of novel, targeted immune therapies. Journal of Allergy and Clinical Immunology. 2017 Sep;140(3):645-653.
8. Brummer GC, Hawkes JE, Duffin KC. Ustekinumab for the treatment of recalcitrant guttate psoriasis: a case series. JAAD Case Reports. 2017 Sep 1;3(5):432-435.
9. Fuentes-Duculan J, Bonifacio KM, Hawkes JE, Kunjravia N, Cueto I, Li X, Gonzalez J, Garcet S, Krueger JG. Autoantigens ADAMTSL5 and LL37 are significantly upregulated in active Psoriasis and localized with keratinocytes, dendritic cells and other leukocytes. Experimental Dermatology. 2017 Nov; 26(11):1075-1082.
10. Hawkes JE, Nguyen GH, Fujita M, Florell SR, Callis Duffin KC, Krueger GG, O’Connell RM. microRNAs in Psoriasis. Journal of Investigative Dermatology. 2016 Feb; 136(2):365-371.